FGFR3 signaling and function in triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) accounts for 16% of breast cancers and represents an aggressive subtype that lacks targeted therapeutic options. In this study, mass spectrometry (MS)-based tyrosine phosphorylation profiling identified aberrant FGFR3 activation in a subset of TNBC ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Chew, Nicole J., Nguyen, Elizabeth V., Su, Shih-Ping, Novy, Karel, Chan, Howard C., Nguyen, Lan K., Luu, Jennii, Simpson, Kaylene J., Lee, Rachel S., Daly, Roger J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986078/
https://www.ncbi.nlm.nih.gov/pubmed/31987043
http://dx.doi.org/10.1186/s12964-019-0486-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986078/
https://www.ncbi.nlm.nih.gov/pubmed/31987043
http://dx.doi.org/10.1186/s12964-019-0486-4

Ejemplares similares